Several relative risk models for survival time data in drug combination therapy are derived and their properties are discussed. The main intention of this paper is to clarify the differences among the models in order to help to choose the appropriate one in a given situation. The models are motivated by discussing their relation to well-known physiological concepts. In an example of two-drug treatment the models are compared with each other. For this chemotherapy animal survival study, dose-risk surfaces are fitted and optimal drug combinations are estimated. Methods for checking the model assumptions are mentioned.
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.